2018
DOI: 10.18632/aging.101411 View full text |Buy / Rent full text
|
|

Abstract: The use of human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) is limited in drug discovery and cardiac disease mechanism studies due to cell immaturity. Although many approaches have been reported to improve the maturation of hiPSC-CMs, the elucidation of the process of maturation is crucial. We applied a small-molecule-based differentiation method to generate cardiomyocytes (CMs) with multiple aggregation forms. The motion analysis revealed significant physical differences in the different… Show more

Help me understand this report

Search citation statements

Order By: Relevance
Select...
0
5
0

Publication Types

Select...

Relationship

0
0

Authors

Journals